Product category:
Liquid handling
News Release from: Corning Life Sciences | Subject: Epic LHA
Edited by the Laboratorytalk Editorial
Team on 03 April 2008
Integrated liquid handling for the epic
system
Corning has announced the introduction of an automated liquid-handling accessory (LHA) that integrates with its Epic system, to enable automated label-free biochemical and cell-based assays
"Corning developed this innovative accessory to meet the increasing demand for integrated liquid-handling capability with label-free assays," said Ron Verkleeren, business director, Corning Epic "This new accessory provides our Epic customers with the added benefit of automated liquid handling and plate stacking in an easy-to-use, compact footprint"
This article was originally published on Laboratorytalk on 16 Mar 2004 at 8.00am (UK)
Related stories
Surface promises enhanced cell attachment
Highly stable surface provides greater cell yields and reproducibility, making it easier to grow fastidious cells under difficult conditions, such as reduced-serum or serum-free medium
Low tech approach to cell culture scale up
Expanded product offering means less capital investment and further accommodates customer requirements for manufacturing flexibility and ease of use
The Epic LHA includes a 384-well pipettor, a microplate stacker that can handle up to 20 lidded 384-well microplates and an automated tip wash station.
The liquid-handling system has been designed to maintain thermal stability in order to eliminate artifacts from laboratory temperature fluctuations.
The Corning Epic system is described as the world's first high-throughput label-free drug discovery system.
It uses patented optical biosensor technology to perform label-free biochemical and cell-based assays.
The system is sensitive enough to measure the cell response from endogenous receptor expression on primary or non-engineered cell lines, along with protein/drug direct binding events in biochemical assays.
It has been sold and deployed to customer sites in North America, Europe and Asia since its launch in 2006.
"The addition of the LHA to our product portfolio is evidence of our commitment to meet customer needs and to maintain our leadership in label-free detection", Verkleeren added.
Corning has built an extensive patent portfolio related to the Epic System and label-free optical biosensor technology, including the acquisition of exclusive rights to US Patent 5,738,825, a fundamental patent related to optical based biosensors in a microplate format.
• Corning Life Sciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
